Filing Flows › Iradimed (IRMD) › Q2 2025
Iradimed (IRMD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 1, 2025
Iradimed (IRMD) reported revenue of $20.4M for the second quarter 2025 (Q2 2025), +14% from a year earlier and +5% from the quarter before. Operating margin was 33.3%, net earnings $5.8M (28.3% of revenue).
Iradimed, Q2 2025: revenue $20.4M (+14% year over year), operating margin 33.3%, net earnings $5.8M, operating cash flow $7.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.4M | +5% | +14% |
| Gross profit | $16.0M | +7% | +14% |
| Operating profit | $6.8M | +25% | +21% |
| Net earnings | $5.8M | +23% | +18% |
| Operating cash flow | $7.7M | +80% | +17% |
| Free cash flow | $4.9M | — | -8% |
What changed
Revenue was $20.4M in Q2 2025, up 14% year over year and up 5% from the previous quarter.
Gross margin was 78.2%, unchanged from a year earlier. Operating profit was $6.8M, a 33.3% margin (up 1.9 points year over year). Of the extra revenue versus a year earlier, 47% reached operating profit, above the 31% margin then. Operating expenses grew 9% against revenue growth of 14%. The fastest-growing cost line was Sales & marketing (+15%). Net earnings were $5.8M, up 18% year over year. The effective tax rate was 21.2%.
Operating cash flow was $7.7M (up 17% year over year), 134% of net earnings. Non-cash charges added back $208K of depreciation and amortization and $731K of share-based compensation. Working capital and other items added $1.0M. After capital Expenditures ($2.8M), free cash flow as the company reports it was $4.9M.
Questions
What was Iradimed's revenue in the second quarter 2025?
Iradimed (IRMD) reported revenue of $20.4M for the second quarter 2025 (Q2 2025), +14% from a year earlier and +5% from the quarter before.
Was Iradimed profitable in the second quarter 2025?
Operating profit was $6.8M (33.3% of revenue) and net earnings $5.8M.
Source: Iradimed 10-Q on SEC EDGAR.